Global Metabolomics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

List of Tables

The global demand for Metabolomics Market is presumed to reach the market size of nearly USD 11.82 BN by 2030 from USD 3.89 BN in 2022 with a CAGR of 14.9% under the study period 2023 - 2030.

Metabolomics is a field of scientific study that focuses on the comprehensive analysis and measurement of small molecules, known as metabolites, within a biological system. It aims to identify and quantify metabolites present in biological samples, such as blood, urine, tissues, or cells, and to understand their roles in different biological processes. The analysis of metabolites provides valuable insights into the metabolic state, biochemical changes, and overall physiological condition of an organism.

MARKET DYNAMICS:

The advancements in analytical techniques, such as mass spectrometry and nuclear magnetic resonance spectroscopy, have expanded the capabilities and sensitivity of metabolomics analysis, driving its demand in research and applications. The shift towards personalized medicine has created a demand for comprehensive profiling of patients' metabolomes. The study plays a crucial role in identifying unique metabolic signatures associated with diseases, enabling early diagnosis, stratification of patients, and personalized treatment approaches. The need for accurate biomarkers for disease detection, prognosis, and therapeutic monitoring also fuels the adoption of metabolomics. It is used for drug discovery and development in the pharmaceutical and biotechnology industries. It aids in understanding drug metabolism, identifying drug targets, and assessing drug safety profiles, contributing to optimized drug development processes and patient outcomes. Metabolomics finds applications in agriculture and food science, contributing to crop improvement, food quality assessment, and understanding plant and microbial metabolism. Government initiatives, supportive funding, and collaborations within the scientific community further drive the growth and adoption of this market.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of metabolomics. The growth and trends of metabolomics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the metabolomics market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Metabolomics Instruments
Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis)
Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis)

By Bioinformatics Tools And Services

Bioinformatics Services
Bioinformatics Tools And Databases

By Appication

Biomarker Discovery
Drug Discovery
Toxicology Testing
Nutrigenomics
Functional Genomics
Personalized Medicine
Other

By Indication

Cancer
Cardiovascular Disorders
Neurological Disorders
Metabolic Disorders
Inborn Errors Of Metabolism
Other

By End User

Academic And Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Other

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Metabolomics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the metabolomics market include Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific (US), Danaher Corporation (US), Bruker Corporation (US), PerkinElmer (US), Merck KGaA (Germany), GE Healthcare (US), Hitachi High- Technologies Corporation (Japan). Human Metabolome Technologies, Inc. (Japan), LECO Corporation (US). Metabolon, Inc. (US), Bio-Rad Laboratories (US), Scion Instruments (US), DANI Instruments S.p.A. (Italy), GL Sciences (Japan), SRI Instruments (US), Kore Technology Ltd. (UK), and JASCO, Inc. (US) (Total 20 companies). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

Product Code: VMR112111504

1 . PREFACE

1.1. Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . METABOLOMICS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Bioinformatics Tools And Services
- 3.7.3 Market Attractiveness Analysis By Appication
- 3.7.4 Market Attractiveness Analysis By Indication
- 3.7.5 Market Attractiveness Analysis By End User
- 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL METABOLOMICS MARKET ANALYSIS BY PRODUCT & SERVICE

5.1 Overview by Product & Service
5.2 Historical and Forecast Data
5.3 Analysis by Product & Service
5.4 Metabolomics Instruments Historic and Forecast Sales by Regions
5.5 Separation Tools (Gas Chromatography, High-Performance Liquid Chromatography, Ultra-Performance Liquid Chromatography, Capillary Electrophoresis) Historic and Forecast Sales by Regions
5.6 Detection Tools (Nuclear Magnetic Resonance (NMR) Spectroscopy, Mass Spectrometry (MS), Surface-Based Mass Analysis) Historic and Forecast Sales by Regions

6 . GLOBAL METABOLOMICS MARKET ANALYSIS BY BIOINFORMATICS TOOLS AND SERVICES

6.1 Overview by Bioinformatics Tools And Services
6.2 Historical and Forecast Data
6.3 Analysis by Bioinformatics Tools And Services
6.4 Bioinformatics Services Historic and Forecast Sales by Regions
6.5 Bioinformatics Tools And Databases Historic and Forecast Sales by Regions

7 . GLOBAL METABOLOMICS MARKET ANALYSIS BY APPICATION

7.1 Overview by Appication
7.2 Historical and Forecast Data
7.3 Analysis by Appication
7.4 Biomarker Discovery Historic and Forecast Sales by Regions
7.5 Drug Discovery Historic and Forecast Sales by Regions
7.6 Toxicology Testing Historic and Forecast Sales by Regions
7.7 Nutrigenomics Historic and Forecast Sales by Regions
7.8 Functional Genomics Historic and Forecast Sales by Regions
7.9 Personalized Medicine Historic and Forecast Sales by Regions
7.10. Other Historic and Forecast Sales by Regions

8 . GLOBAL METABOLOMICS MARKET ANALYSIS BY INDICATION

8.1 Overview by Indication
8.2 Historical and Forecast Data
8.3 Analysis by Indication
8.4 Cancer Historic and Forecast Sales by Regions
8.5 Cardiovascular Disorders Historic and Forecast Sales by Regions
8.6 Neurological Disorders Historic and Forecast Sales by Regions
8.7 Metabolic Disorders Historic and Forecast Sales by Regions
8.8 Inborn Errors Of Metabolism Historic and Forecast Sales by Regions
8.9 Other Historic and Forecast Sales by Regions

9 . GLOBAL METABOLOMICS MARKET ANALYSIS BY END USER

9.1 Overview by End User
9.2 Historical and Forecast Data
9.3 Analysis by End User
9.4 Academic And Research Institutes Historic and Forecast Sales by Regions
9.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
9.6 Contract Research Organizations Historic and Forecast Sales by Regions
9.7 Other Historic and Forecast Sales by Regions

10 . GLOBAL METABOLOMICS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Data Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Data Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Data Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Data Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Data Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE METABOLOMICS COMPANIES

11.1. Metabolomics Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12 . COMPANY PROFILES OF METABOLOMICS INDUSTRY

12.1. Company Share Analysis
12.2. Market Concentration Rate
12.3. Waters Corporation (US)
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
12.4. Agilent Technologies (US)
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
12.5. Shimadzu Corporation (Japan)
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
12.6. Thermo Fisher Scientific (US)
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
12.7. Danaher Corporation (US)
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
12.8. Bruker Corporation (US)
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
12.9. PerkinElmer (US)
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
12.10. Merck KGaA (Germany)
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
12.11. GE Healthcare (US)
- 12.11.1. Company Overview
- 12.11.2. Company Revenue
- 12.11.3. Products
- 12.11.4. Recent Developments
12.12. Hitachi High- Technologies Corporation (Japan)
- 12.12.1. Company Overview
- 12.12.2. Company Revenue
- 12.12.3. Products
- 12.12.4. Recent Developments
12.13. Human Metabolome Technologies Inc. (Japan)
- 12.13.1. Company Overview
- 12.13.2. Company Revenue
- 12.13.3. Products
- 12.13.4. Recent Developments
12.14. LECO Corporation (US)
- 12.14.1. Company Overview
- 12.14.2. Company Revenue
- 12.14.3. Products
- 12.14.4. Recent Developments
12.15. Metabolon Inc. (US)
- 12.15.1. Company Overview
- 12.15.2. Company Revenue
- 12.15.3. Products
- 12.15.4. Recent Developments
12.16. Bio-Rad Laboratories (US)
- 12.16.1. Company Overview
- 12.16.2. Company Revenue
- 12.16.3. Products
- 12.16.4. Recent Developments
12.17. Scion Instruments (US)
- 12.17.1. Company Overview
- 12.17.2. Company Revenue
- 12.17.3. Products
- 12.17.4. Recent Developments
12.18. DANI Instruments S.p.A. (Italy)
- 12.18.1. Company Overview
- 12.18.2. Company Revenue
- 12.18.3. Products
- 12.18.4. Recent Developments
12.19. GL Sciences (Japan)
- 12.19.1. Company Overview
- 12.19.2. Company Revenue
- 12.19.3. Products
- 12.19.4. Recent Developments
12.20. SRI Instruments (US)
- 12.20.1. Company Overview
- 12.20.2. Company Revenue
- 12.20.3. Products
- 12.20.4. Recent Developments
12.21. Kore Technology Ltd. (UK)
- 12.21.1. Company Overview
- 12.21.2. Company Revenue
- 12.21.3. Products
- 12.21.4. Recent Developments
12.22. JASCO Inc. (US)
- 12.22.1. Company Overview
- 12.22.2. Company Revenue
- 12.22.3. Products
- 12.22.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies